Noteably, CD44(+)/CD24(-/low) breast cancer stem-like cells are associated with tumor recurrence [24] and play a pivotal role in the clinical behavior of triple-negative breast cancer, a particularly therapy-resistant subclass of breast cancer [25]. Here, CD44 is linked to breast cancer.